BioCentury
ARTICLE | Company News

Prosonix, Mylan deal

April 21, 2014 7:00 AM UTC

Mylan received rights to market Prosonix's generic versions of asthma product Flixotide/ Flovent from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK, London, U.K.) in several regions, including the U.S., EU...